Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.
about
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal DiseaseEverolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomesNew-Generation Coronary Stents: Current Data and Future Directions.Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialCoronary stent thrombosis: what have we learned?Organ transplantation and drug eluting stents: Perioperative challenges.Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).Drug-eluting stents to prevent stent thrombosis and restenosis.Clinical implications of blood-material interaction and drug eluting stent polymers in review.Adverse cardiovascular events associated with biodegradable polymer drug-eluting stents and durable polymer everolimus-eluting stents: A systematic review and meta-analysis of 10 randomized controlled trials.From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.Percutaneous Coronary Intervention: 2015 in Review.Effect of biodegradable polymer drug-eluting stents versus biocompatible polymer everolimus-eluting stents: a meta-analysis.Safety and efficacy outcomes of 3rd generation DES in an all-comer population of patients undergoing PCI: 12-month and 24-month results of the e-Biomatrix French registry.Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial.Polymer-Free Drug-Coated Coronary Stents in Patients with Stable Coronary Artery Disease at High Bleeding Risk.Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.Bioresorbable Scaffolds for Coronary Artery Disease.Procedural resources utilization and clinical outcomes with bioresorbable everolimus-eluting scaffolds and Pt-Cr everolimus-eluting stent with resorbable abluminal polymer in clinical practice. A randomized trial.Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.Comparison on the efficacy of everolimus-eluting stent and zotarolimus-eluting stents in coronary heart disease between diabetic and non-diabetic patients.Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography study.Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial.Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.Very Late Pathological Responses to Cobalt-Chromium Everolimus-Eluting, Stainless Steel Sirolimus-Eluting, and Cobalt-Chromium Bare Metal Stents in Humans.Bilirubin coating attenuates the inflammatory response to everolimus-coated stents.Development and validation of a risk model for long-term mortality after percutaneous coronary intervention: The IDEA-BIO Study.Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and coVery early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.Optical frequency-domain imaging findings to predict good stent expansion after rotational atherectomy for severely calcified coronary lesions.Real life experience with bioresorbable-polymer everolimus-eluting stents. Is this an answer in search of a question?Revisiting the role of durable polymers in cardiovascular devices.Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial.Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents.Treatment of coronary in-stent restenosis: a systematic review.Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.Novel Polymer-Free Everolimus-Eluting Stent Fabricated using Femtosecond Laser Improves Re-endothelialization and Anti-inflammation.Procedural advantages of a novel coronary stent design with ultra-thin struts and bioabsorbable abluminal polymer coating in an all-comers registry
P2860
Q26739024-FFAF88EC-048C-46F0-86AB-72685D1F03A3Q26798582-A344D3EB-AA81-475A-AAE8-88C727384DECQ31164040-075BFA63-A863-462D-8C45-351FDD1D7907Q37090890-2155FAA6-BF78-49AD-A7AE-31C7CD8A8810Q37121422-1331799B-2505-4CE1-8C9D-4EB8CEF537B0Q37522553-B3F65D27-AC6F-4C02-9F21-2B13147A96F2Q38372442-79663D79-2CDA-4CC6-BE5F-250DAA1DE1FBQ38633332-9D2F05C2-375F-4A5C-8F05-E94EFB1F1762Q38645043-A32CEC73-C792-49D2-9264-DDB06121A7CEQ38682427-6410C2ED-0B79-4509-8A25-64BD85D1B523Q38702003-6629CB1F-9E67-4FA1-9865-B4E338F270A2Q38728869-4BFE3420-79E0-4200-B122-259D9743D520Q38734700-D8D2C80C-F1CA-4BB3-B811-511CA18F6B3AQ38764070-25A2C96E-F726-49E2-8E24-3328FC54D694Q38764106-D263056B-8654-40D0-A7B9-437665C0BE62Q38818354-614B612D-63E0-49B5-BD40-4D024A3CF6DEQ38968542-CF162C99-100E-4468-B941-15D327389A45Q39053571-F2878062-2B41-4C7D-B465-C9714CBB1A2DQ39097196-8DC904CE-1579-4F00-894B-64E0A2CD5A17Q39221658-1539EE42-1407-4454-9F6A-8CA0B5E06836Q39393770-83A1316C-8C9E-4BF0-915F-3C767CAEC746Q39991564-38C4ACE3-7369-4CDF-8DF2-3972DACD82C1Q40261905-0DA36975-30CB-4EE6-830B-7A68AF759CF1Q40364494-DB6F99CA-2BD9-4F4D-9D47-6260EFA953EAQ40559009-2B22874D-5B06-4002-BF48-78218771F223Q46510109-C83EF86C-9282-46E8-8D67-802B2989B364Q47118021-4ECE23EC-FD54-485C-BD87-3AC2B947CCA9Q47943695-9E8430B6-3D5A-49C6-8871-4B4C85FF7E26Q48127066-5C669D1E-E4ED-4277-B7DA-16BBE74BC1D5Q48252185-C67A227D-77D8-4447-8B97-AAE8FF3EC9F3Q48266205-3BCA8F11-42A8-4BB8-B21D-D74700E30C6CQ48274572-9A43D41E-7510-43C9-BF04-4CCF25DE09E1Q48283964-EB0CA952-B281-4E2D-90F8-679DAE5453C0Q49486591-2AC9E9B0-24CF-4662-A3FF-02DB36D549B4Q49985062-5DA30E9E-23CC-4551-AEE5-DCC6C9BB751AQ52581576-28F9F49F-1CC8-4617-B262-7124953C4A23Q52584404-D65A671B-18B9-45BD-B887-210C0242B596Q54960240-DE993718-11C1-4E1D-B4D0-BF182B5AB7CFQ55366209-FD8A305F-8675-46E5-B50C-A41574D5D3B1Q57301703-8C61EF72-E261-4B65-8980-4191A6C776DA
P2860
Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and safety of a novel ...... he EVOLVE II Randomized Trial.
@en
type
label
Efficacy and safety of a novel ...... he EVOLVE II Randomized Trial.
@en
prefLabel
Efficacy and safety of a novel ...... he EVOLVE II Randomized Trial.
@en
P2093
P1476
Efficacy and safety of a novel ...... he EVOLVE II Randomized Trial.
@en
P2093
Bernardo Stein
Christophe Dubois
Dean J Kereiakes
Dominic J Allocco
Ian J Sarembock
Ian T Meredith
Keith D Dawkins
R Lee Jobe
Robert L Feldman
Shamir R Mehta
P356
10.1161/CIRCINTERVENTIONS.114.002372
P577
2015-04-01T00:00:00Z